Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations

NCT01574898 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pierre Fabre Medicament